Jimmy Shan

Stock Analyst at RBC Capital

(3.28)

# 904

Out of 4,820 analysts

13

Total ratings

64.29%

Success rate

10.65%

Average return

Main Sectors:

Healthcare Real Estate

Top Industries:

Biotechnology Real Estate Services

Stocks Rated by Jimmy Shan

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TRML Tourmaline Bio	Initiates: Outperform	$58	$16.87	+243.81%	1	Feb 24, 2025
	CIGI Colliers International Group	Maintains: Outperform	$170 → $175	$115.42	+51.62%	12	Feb 7, 2025

Tourmaline Bio

Feb 24, 2025

Initiates: Outperform

Price Target: $58

Current: $16.87

Upside: +243.81%

Colliers International Group

Feb 7, 2025

Maintains: Outperform

Price Target: $170 → $175

Current: $115.42

Upside: +51.62%